2nd International Congress on Advanced Treatments in Rare Diseases (RARE2019)
From 04 to 05 March 2019
At : Vienna, Austria.
//= $linkOg ?>
From 04 to 05 March 2019
At : Vienna, Austria.
From 04 to 06 March 2019
At : London, United Kingdom.
From 25 to 28 March 2019
At : Bordeaux, France
On 21 June 2019
At : Salzburg, Austria
From 06 to 08 November 2019
At : Madrid, Spain
From 19 to 23 January 2020
At : London, UK
From 11 to 15 March 2019
At : Imagine Institute, Paris, France
Applications are now open. Applicants will be notified of the outcome of their application by mid October.
Several training workshops on rare disease sample management will be organised during the EJP RD run time. Workshop themes may vary from year to year, based on feedback from participants and EJP RD project outputs.
In 2019, the workshop theme is “Organizing & maximizing rare disease biological sample data in biobanks “.
Two workshops are available in 2019 and will have similar contents. The two workshops may vary only slightly to tailor the local organisers logistical or needs.
Workshop 1 1-2 April 2019, Milan, Italy
Workshop 2 29-30 October, Vilnius, Lithuania
DEBRA International is inviting research proposals for the ‘All-Priorities‘ Research Call. There is a one stage application process with a submission deadline by March 11, 2019.
The ‚All-Priorities‘ Research Project grants scheme calls for research proposals across DEBRA's four priority research areas:
Funding up to €270.000 over three years
Research proposals must be submitted online.
Closing date for applications Monday, March 11, 2018 at 17:00 GMT.
Background
The Myotubular Trust (UK Registered Charity No: 1137177) was set up in 2006 to raise money for research to find a cure and / or treatment for any of the genetic forms of centronuclear and myotubular myopathy.
There are a number of genetically distinct forms of centronuclear myopathy. The commonest is x-linked, usually called myotubular myopathy, affecting in the vast majority of cases, only boys. It is also usually the most severe, presenting in the new-born period and there are associated breathing and swallowing difficulties in addition to the general muscle weakness. The other forms are either dominant or recessive in inheritance, are usually, but not always, milder, and vary widely.
2019 call for projects
Myotubular Trust is holding a 2019 call for research grants. We will require completed applications by 1700 hours GMT Friday 15th March 2019. We anticipate making awards in late June / early July.
We are looking to fund further projects that will help find a cure and / or a treatment for any form of centronuclear and myotubular myopathy (congenital X-linked recessive; congenital autosomal recessive; autosomal dominant), focusing on research that would not generally be funded by public or industrial funding sources. This call will be open to research bodies internationally.
We will be looking for the following types of application:
1. A project grant applied for by a Principal Investigator to fund a project for 2-3 years duration to be carried out by a Post-Doctoral researcher, or PHD student
2. A Myotubular Trust fellowship – basic science (3-4 years duration), where the scientist has identified a group that he or she wants to work with. Award is made to a named individual.
In particular, we would like to encourage the application of new technologies to research into centronuclear and myotubular myopathy; interventional trials; and those which may involve collaboration between different medical disciplines and / or different research institutions. We are also willing to consider applications which involve joint funding with other organisations.
Myotubular Trust’s Scientific Advisory Board (SAB) is chaired by Professor Francesco Muntoni of The Institute of Child Health, University College London. The SAB makes recommendations to the Myotubular Trust Trustees on which projects to fund, based on scientific assessment and peer review.
Further information
Further guidance and application forms can be found on the website.
Contact - research@myotubulartrust.org
Please send your CV and cover letter to with the reference US14-2018-16 to:
Please send your CV and cover letter to with the reference US14-2018-14 to:
Please send your CV and cover letter to with the reference 2019-US14-002 to:
Located in Paris at the heart of the largest European hospital, Pitié-Salpêtrière, the Institute of Myology was created in 1996 by AFM-Telethon, a patient’s organization. Its goal: Promote Myology and have it accepted as a standalone clinical and scientific discipline. The Institute of Myology coordinates, around the patient, medical care, basic research, applied research, clinical research and teaching.
This fixed term contract, based at the Institute of Myology (Hôpital Pitié Salpêtrière, Paris 13) is to be filled on a full-time basis.
For further details consult the Myology website.
Thank you to send your application (CV + motivation letter) to the following address: recrutement-aim@institut-myologie.org
Located in Paris at the heart of the largest European hospital, Pitié-Salpêtrière, the Institute of Myology was created in 1996 by AFM-Telethon, a patient’s organization. Its goal: Promote Myology and have it accepted as a standalone clinical and scientific discipline. The Institute of Myology coordinates, around the patient, medical care, basic research, applied research, clinical research and teaching.
This fixed term contract, based at the Institute of Myology (Hôpital Pitié Salpêtrière, Paris 13) is to be filled on a full-time basis.
For further details consult the Myology website.
Thank you to send your application (CV + motivation letter) to the following address: recrutement-aim@institut-myologie.org